| 1 | Achieved - 13/02/2024 | Remplir regulatory submission - Singapore |
|---|
| 2 | Achieved - 11/06/2024 | SmrtGraft regulatory submission - Australia |
|---|
| 3 | Guidance4Q CY24 - 11/07/2024 (early) | Striate+ regulatory approval - Canada |
|---|
| 4 | 3Q CY24 -> delayed until 4Q CY24 | Remplir registration study results - US |
|---|
| 5 | 30/08/2024 | 2024 Annual Report |
|---|
| 6 | 30/08/2024 | Company Presentation |
|---|
| 7 | 4Q CY24 (13/2 + 240d = 10/10/24?) Achieved -8/10/24 | Remplir regulatory approval - Singapore |
|---|
| 8 | October 2024 | 1Q FY25 Financial Report |
|---|
| 9 | 4Q CY24(25/3 + 24w + 6w = 21/10/24?) | Remplir registration study results - US |
|---|
| 10 | 4Q CY24 (December?) | Remplir regulatory submission - US |
|---|
| 11 | 4Q CY24 or 1Q CY25? | Remplir distribution partner(s) ~ Multiple partners or an exclusive global partner? |
|---|
| 12 | 4Q CY24 (December?) | Remplir regulatory submission - Canada |
|---|
| 13 | 4Q CY24 - 1Q CY25(11/6/24 + 6-9mth) | SmrtGraft regulatory approval - Australia |
|---|
| 14 | 1Q CY25? | SmrtGraft distribution partner - Australia |
|---|
| 15 | 1Q-3Q CY25? (Mar, July, Nov?) | SmrtGraft reimbursement grant - Australia |
|---|
| 16 | CY25 (3Q CY25?) | SmrtGraft commercial launch - Australia |
|---|
| 17 | 1Q-2Q CY25? | Remplir commercial launch - Singapore |
|---|
| 18 | January 2025 | 2Q FY25 Financial Report |
|---|
| 19 | February 2025 | 1H FY25 Financial Report |
|---|
| 20 | 1H CY25? | Striate+ regulatory submission - Japan |
|---|
| 21 | 1H CY25? | Striate+ regulatory submission - Columbia |
|---|
| 22 | 1Q CY25(March?) | Remplir regulatory approval - US |
|---|
| 23 | 2Q CY25 | Remplir commercial launch - US |
|---|
| 24 | April 2025 | 3Q FY25 Financial Report |
|---|
| 25 | 2Q CY25 | Striate+ regulatory approval - Brazil |
|---|
| 26 | 3Q CY25? | Striate+ commercial launch - Brazil |
|---|
| 27 | 2Q CY25 | Remplir regulatory submission - Thailand |
|---|
| 28 | 2Q CY25? | R&D tax incentive refund |
|---|
| 29 | July 2025 | 4Q FY25 Financial Report |
|---|
| 30 | 3Q CY25 | Striate+ regulatory approval - Singapore |
|---|
| 31 | 3Q CY25? | Striate+ commercial launch - Singapore |
|---|
| 32 | August 2025 | FY25 Annual Report |
|---|
| 33 | 3Q CY25 | Remplir regulatory approval - Canada |
|---|
| 34 | 4Q CY25? | Remplir commercial launch - Canada |
|---|
| 35 | 3Q CY25 | Remplir regulatory submission - EU/UK |
|---|
| 36 | 4Q CY25? | Remplir regulatory submission - Japan |
|---|
| 37 | October 2025 | 1Q FY26 Financial Report |
|---|
| 38 | CY24/25 | OrthoATI IND application - US |
|---|
| 39 | CY24/25 | OrthoATI RMAT application - US |
|---|
| 40 | CY25 | OrthoATI IND approval - US |
|---|
| 41 | CY25 | OrthoATI RMAT approval - US |
|---|
| 42 | CY24/25 | OrthoATI partnership - US or global |
|---|
| 43 | CY25? | OrthoATI regulatory submission - Australia (Waiting for partner/trials/funds?) |
|---|
| 44 | CY25? | Manufacturing Facility Expansion |
|---|
| 45 | CY25? | SmrtGraft regulatory submissions - Global |
|---|
| 46 | CY25? | CelGro Rope - design & commence studies |
|---|
| 47 | CY25? | Possible takeover target |
|---|
| 48 | 2Q CY26(2Q CY25 + 12wk = 3Q CY25?) | Remplir regulatory approval - Thailand |
|---|
| 49 | 3Q CY26 | Remplir regulatory approval - EU/UK |
|---|
| 50 |
|
|
|---|
(20min delay)